These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 12517798)

  • 1. Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells.
    Arboleda MJ; Lyons JF; Kabbinavar FF; Bray MR; Snow BE; Ayala R; Danino M; Karlan BY; Slamon DJ
    Cancer Res; 2003 Jan; 63(1):196-206. PubMed ID: 12517798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt2: a role in breast cancer metastasis.
    Chau NM; Ashcroft M
    Breast Cancer Res; 2004; 6(1):55-7. PubMed ID: 14680486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin β1 mediates epithelial growth factor-induced invasion in human ovarian cancer cells.
    Lau MT; So WK; Leung PC
    Cancer Lett; 2012 Jul; 320(2):198-204. PubMed ID: 22388103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells.
    Liu AX; Testa JR; Hamilton TC; Jove R; Nicosia SV; Cheng JQ
    Cancer Res; 1998 Jul; 58(14):2973-7. PubMed ID: 9679957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of 3-phosphoinositide-dependent protein kinase-1 levels inhibits migration and experimental metastasis of human breast cancer cells.
    Liu Y; Wang J; Wu M; Wan W; Sun R; Yang D; Sun X; Ma D; Ying G; Zhang N
    Mol Cancer Res; 2009 Jun; 7(6):944-54. PubMed ID: 19531564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AKT involvement in cisplatin chemoresistance of human uterine cancer cells.
    Gagnon V; Mathieu I; Sexton E; Leblanc K; Asselin E
    Gynecol Oncol; 2004 Sep; 94(3):785-95. PubMed ID: 15350374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of Akt2 expression inhibits chemotaxis signal transduction in human breast cancer cells.
    Wang J; Wan W; Sun R; Liu Y; Sun X; Ma D; Zhang N
    Cell Signal; 2008 Jun; 20(6):1025-34. PubMed ID: 18353613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD98 modulates integrin beta1 function in polarized epithelial cells.
    Cai S; Bulus N; Fonseca-Siesser PM; Chen D; Hanks SK; Pozzi A; Zent R
    J Cell Sci; 2005 Mar; 118(Pt 5):889-99. PubMed ID: 15713750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas.
    Ruggeri BA; Huang L; Wood M; Cheng JQ; Testa JR
    Mol Carcinog; 1998 Feb; 21(2):81-6. PubMed ID: 9496907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells.
    Chen YX; Wang Y; Fu CC; Diao F; Song LN; Li ZB; Yang R; Lu J
    Endocr Relat Cancer; 2010 Mar; 17(1):39-50. PubMed ID: 19776289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
    Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
    IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis.
    Page C; Lin HJ; Jin Y; Castle VP; Nunez G; Huang M; Lin J
    Anticancer Res; 2000; 20(1A):407-16. PubMed ID: 10769688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors.
    Fuchs M; Hutzler P; Brunner I; Schlegel J; Mages J; Reuning U; Hapke S; Duyster J; Hirohashi S; Genda T; Sakamoto M; Uberall F; Höfler H; Becker KF; Luber B
    Exp Cell Res; 2002 Jun; 276(2):129-41. PubMed ID: 12027444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.
    van der Pluijm G; Sijmons B; Vloedgraven H; Deckers M; Papapoulos S; Löwik C
    J Bone Miner Res; 2001 Jun; 16(6):1077-91. PubMed ID: 11393785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells.
    Fiucci G; Ravid D; Reich R; Liscovitch M
    Oncogene; 2002 Apr; 21(15):2365-75. PubMed ID: 11948420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.
    Sun M; Paciga JE; Feldman RI; Yuan Z; Coppola D; Lu YY; Shelley SA; Nicosia SV; Cheng JQ
    Cancer Res; 2001 Aug; 61(16):5985-91. PubMed ID: 11507039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma.
    Tokunaga E; Oki E; Kimura Y; Yamanaka T; Egashira A; Nishida K; Koga T; Morita M; Kakeji Y; Maehara Y
    Breast Cancer Res Treat; 2007 Mar; 101(3):249-57. PubMed ID: 17006756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the phosphatidylinositol 3-kinase/Akt pathway prevents radiation-induced apoptosis in breast cancer cells.
    Söderlund K; Pérez-Tenorio G; Stål O
    Int J Oncol; 2005 Jan; 26(1):25-32. PubMed ID: 15586221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.